Search results
Results From The WOW.Com Content Network
Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro and Orsema, developed by a little-known Bangladeshi drugmaker, Incepta ...
The company is now concentrating its efforts in the area of export of Biological products like GCSF, EPO, Adalimumab, and vaccines. In 2015, Incepta launched a generic version of sofosbuvir (Hopetavir) in the local Bangladeshi market. In 2016, Incepta signed a deal with Bioengineering and German AMS Technology for a joint venture. [3]
In 2010, Brummer & Partners Asset Management (Bangladesh) Limited purchases a stake in Impress-Newtex Composite Textiles limited and announced further investment in the company to expand production capacity. [8] Incepta Pharmaceuticals starts manufacturing vaccines in Bangladesh in 2011. It is the first local vaccine manufacturer in Bangladesh. [3]
The following is a list of prominent companies and organizations with their main headquarters in Nairobi: . East African Breweries; Equity Group Holdings Limited; Gulf African Bank
Kenya has ordered an immediate suspension on private importations of vaccines citing fears that it may lead to counterfeit inoculations... View Article The post Kenya stops private importation of ...
The company had said in 2022 that it would invest about $500 million in the Kenya facility and supply as many as 500 million doses of its mRNA vaccines to Africa each year.
On 16 August, a deal signed between the Bangladesh government, China's Sinopharm and Bangladesh's Incepta Vaccines Ltd for bottling, labelling and dispensing China's Sinopharm BIBP vaccine. [53] On 21 August 2021, Japan has sent 7.81 lakh doses of Astra-Zeneca vaccines under COVAX. [54]
Kenya received over a million doses of the AstraZeneca COVID-19 vaccine on Wednesday, while Rwanda said it was the first in Africa to secure shots from Pfizer, as efforts to inoculate the world's ...